‹All articles

Sawyer's Story: PFS After Topical Finasteride

Sawyer used a finasteride spray for three months. His side effects carried on after he stopped. He tells Moral Medicine about life with PFS.

Sawyer used topical finasteride on his scalp for three months. When he stopped, his side effects didn’t.

If you used a finasteride spray or lotion and something changed that hasn’t gone back, his account may sound familiar.

Moral Medicine titled the interview “I Thought I Had a Brain Tumor”. In it, Sawyer talks about post-finasteride syndrome (PFS): side effects that continue after stopping the medicine.

A spray is put on the skin rather than swallowed. What do regulators know about it?

Can a finasteride spray cause lasting side effects?

Some people have reported it. In 2025 the US Food and Drug Administration (FDA) described 32 reports linked to compounded finasteride sprays and solutions, made between 2019 and 2024. They included sexual problems, mood changes, poor sleep, fatigue, brain fog and testicular pain. The FDA said most reports stated the problems “continued to persist after product discontinuation”.

Reports like these can’t show how often it happens. Nobody has counted that yet. For finasteride tablets, the UK medicines regulator warns that sexual side effects have sometimes continued after people stopped (MHRA). The EU medicines regulator reviewed the sprays in 2025 and added no new warning to their leaflets.

The MHRA also linked finasteride tablets to depression and suicidal thoughts. If you’re struggling, you can call Samaritans on 116 123, day or night.

If this has happened to you, you can report it, even years after stopping. Say you used it on your scalp, and write Post 5-alpha-reductase inhibitor syndrome (MedDRA 10082430).

Support Moral Medicine

Moral Medicine recorded Sawyer’s interview. You can find more accounts like his on the Moral Medicine YouTube channel.

Sources

  1. US Food and Drug Administration, FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products, 2025.
  2. MHRA, Finasteride: reminder of the risk of psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment), Drug Safety Update, 29 April 2024.
  3. European Medicines Agency, Finasteride- and dutasteride-containing medicinal products: referral, European Commission decision 22 August 2025.

If this is your story and you would rather it was not here, write to contact@sidefxhub.com. We will take the page down within 48 hours, and you do not have to tell us why.

By Morten SkovPublished Updated

SIDEfxHUB is a patient charity. We are not health professionals, and this does not replace medical advice. Don't start, stop or change any medicine because of what you read here. Talk to your doctor first.

If you are in crisis:116 123 Samaritans (UK)988 Lifeline (US)Find a helpline

SIDEfxHUB Registry

640+ people have joined the registry.
Join them, then report your side effects.

Free. Sign up takes 2 minutes.

Live 640+ people counted so far Each dot is one person 62countries 3conditions